Aortic and Mitral Valve Endocarditis—Simply Left-Sided Endocarditis or Different Entities Requiring Individual Consideration?—Insights from the CAMPAIGN Database
<b>Background</b>: Aortic valve infective endocarditis (AV-IE) and mitral valve infective endocarditis (MV-IE) are often grouped together as one entity: left-sided endocarditis. However, there are significant differences between the valves in terms of anatomy, physiology, pressure, and calcification tendency. This study aimed to compare AV-IE and MV-IE in terms of patient characteristics, pathogen profiles, postoperative outcomes, and predictors of mortality. <b>Methods</b>: We retrospectively analyzed data from 3899 patients operated on for isolated AV-IE or MV-IE in six German cardiac surgery centers between 1994 and 2018. Univariable and multivariable analyses were performed to analyze the risk factors for 30 day and 1 year mortality. A Log-rank test was used to test for differences in long-term mortality. <b>Results</b>: Patients with MV-IE were more likely to be female (41.1% vs. 20.3%.; <i>p</i> < 0.001). Vegetation was detected more frequently in the MV-IE group (66.6% vs. 57.1%; <i>p</i> < 0.001). Accordingly, the rates of cerebral embolic events (25.4% vs. 17.7%; <i>p</i> < 0.001) and stroke (28.2% vs. 19.3%; <i>p</i> < 0.001) were higher in the MV-IE group. Staphylococci had a higher prevalence in the MV-IE group (50.2% vs. 36.4%; <i>p</i> < 0.001). Patients with MV-IE had comparable 30 day mortality (16.7% vs. 14.6%; <i>p</i> = 0.095) but significantly higher 1 year mortality (35.3% vs. 29.0%; <i>p</i> < 0.001) than those with AV-IE. Kaplan-Meier survival analysis showed significantly lower long-term survival in patients with MV-IE (log-rank <i>p</i> < 0.001). <b>Conclusions</b>: Due to the relevant differences between MV-IE and AV-IE, it might be useful to provide individualized, valve-specific guideline recommendations rather than general recommendations for left-sided IE.
Authors
- Christian M. Hagl
- Hug Aubin (ORCID: https://orcid.org/0000-0001-9289-8927)
- Michael Andrew Borger (ORCID: https://orcid.org/0000-0003-1046-1364)
- Ahmed Elderia (ORCID: https://orcid.org/0000-0002-6859-5384)
- Mateo Marin‐Cuartas (ORCID: https://orcid.org/0000-0003-1000-4710)
- Torsten Doenst (ORCID: https://orcid.org/0000-0002-6411-909X)
- Payam Akhyari (ORCID: https://orcid.org/0000-0002-6452-8678)
- Sems‐Malte Tugtekin (ORCID: https://orcid.org/0009-0004-7321-2490)
- Martín Misfeld (ORCID: https://orcid.org/0000-0001-7940-0629)
- Klaus Matschke (ORCID: https://orcid.org/0000-0003-4544-3967)
- Artur Lichtenberg (ORCID: https://orcid.org/0000-0001-8580-6369)
- Carolyn Weber
- Asen Petrov (ORCID: https://orcid.org/0000-0002-6827-2489)
- Maximilian Luehr (ORCID: https://orcid.org/0000-0002-0645-1764)
- Mahmoud Diab (ORCID: https://orcid.org/0000-0003-1529-6046)
- Thorsten Wahlers (ORCID: https://orcid.org/0000-0002-8437-4119)
- Shekhar Saha (ORCID: https://orcid.org/0000-0002-9903-3237)
- Florian Muench
Institutions
- The University of Sydney (AU)
- University of Cologne (DE)
- Royal Prince Alfred Hospital (AU)
- Leipzig Heart Institute (DE)
- German Centre for Cardiovascular Research (DE)
- Baird Institute (AU)
- Heinrich Heine University Düsseldorf (DE)
- University of Duisburg-Essen (DE)
- Friedrich Schiller University Jena (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2024-09-30
- DOI
- https://doi.org/10.3390/jcm13195841
- Citations
- 4
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.55